Advantages of the Liposomal Form of Xymedon in Leukopoiesis Restoration against the Background of Myelosuppressive Therapy with Liposomal Antineoplastic Drugs in Experiment

A. V. Siprov, M. A. Solov’eva, S. E. Zemskova

Open source

DOI
10.1007/s10517-021-05362-6
Published
2021-12
Container
Bulletin of Experimental Biology and Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10517-021-05362-6,
  title = {Advantages of the Liposomal Form of Xymedon in Leukopoiesis Restoration against the Background of Myelosuppressive Therapy with Liposomal Antineoplastic Drugs in Experiment},
  author = {A. V. Siprov and M. A. Solov’eva and S. E. Zemskova},
  year = {2021},
  journal = {Bulletin of Experimental Biology and Medicine},
  doi = {10.1007/s10517-021-05362-6},
  url = {https://doi.org/10.1007/s10517-021-05362-6}
}

RIS

TY  - JOUR
TI  - Advantages of the Liposomal Form of Xymedon in Leukopoiesis Restoration against the Background of Myelosuppressive Therapy with Liposomal Antineoplastic Drugs in Experiment
AU  - A. V. Siprov
AU  - M. A. Solov’eva
AU  - S. E. Zemskova
PY  - 2021
JO  - Bulletin of Experimental Biology and Medicine
DO  - 10.1007/s10517-021-05362-6
UR  - https://doi.org/10.1007/s10517-021-05362-6
ER  - 

APA

Siprov, A. V., Solov’eva, M. A., & Zemskova, S. E. (2021). Advantages of the Liposomal Form of Xymedon in Leukopoiesis Restoration against the Background of Myelosuppressive Therapy with Liposomal Antineoplastic Drugs in Experiment. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-021-05362-6

Source records